A new law, the Psychoactive Substances Act 2016, comes into effect in the UK in April, it was given royal assent on 28th January. Its purported intent was to counteract the increasing numbers of ‘legal highs’ becoming available in the country.
It goes so far as to prohibit any substance that is psychoactive, with the exceptions of alcohol, tobacco, caffeine, controlled drugs, approved medicinal products, and foods. It includes tryptamines such as you find in ayahuasca herbs. Ayahuasca will be banned as there’s no history of medicinal use in the UK, but products such as St John Wort etc will probably not be affected. Ibogaine, the natural remedy for addiction is covered by the ban.
At one stage, while the psychoactive substances bill was going through Parliament, it was decided to exclude natural substances from the bill. Much of the healing community breathed a sigh of relief, but these plant medicines became included in the ban again later.
The full details can be accessed here.
As of this April, when this Act comes into effect, ibogaine will be effectively prohibited in the United Kingdom. Information has been updated on the Global Ibogaine Therapy Alliance legal status map. http://www.ibogainealliance.org/ibogaine/law
They say “This is further evidence of How Prohibition is Depriving Society from Essential Medicines and Therapeutic Toolshttp: http://www.ibogaineconference.org/blog/how-prohibition-is-depriving-society-from-essential-medicines-and-therapeutic-tools/
In fact, there has been relatively little ibogaine activity in the UK so far anyway, most people from UK go to other countries, notably Mexico for ibogaine treatment.
At the Global Ibogaine Conference in Mexico this March you are invited to
join the discussion about changing drug policies and regulatory frameworks for ibogaine .http://www.ibogaineconference.org
There are some interesting remarks on this development here. “If the government wants to combat the problems caused by new psychoactive substances, a far more effective policy would be to legalise and regulate traditional psychoactive drugs.” Daniel Prior
“health risks will only increase once trade in them has been made illegal, as criminal enterprise is not famed for its insistence on quality control. In essence, the bill is going to provide a profitable and dangerous new market for drug dealers to explore.” Amanda Feilding